🇺🇸 FDA
Patent

US 7105643

Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the same, and crack cocaine conjugates

granted A61KA61K2039/6081A61K39/0013

Quick answer

US patent 7105643 (Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the same, and crack cocaine conjugates) held by The United States of America as represented by the Attorney General of the Dept. of Justice expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Attorney General of the Dept. of Justice
Grant date
Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/6081, A61K39/0013